The trajectory of Sildenafil presents a complex case for investors in the drug sector. While initially a blockbuster success, generating vast sums, the patent end and the subsequent arrival of off-brand competitors https://porn319486.spintheblog.com/42090456/the-little-copyright-and-big-pharma-a-risky-play